MARKET

ARCT

ARCT

Arcturus Therape
NASDAQ
7.57
+0.55
+7.83%
Closed 19:50 02/06 EST
OPEN
7.24
PREV CLOSE
7.02
HIGH
7.63
LOW
7.01
VOLUME
570.36K
TURNOVER
0
52 WEEK HIGH
24.17
52 WEEK LOW
5.85
MARKET CAP
215.10M
P/E (TTM)
-3.0774
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ARCT last week (0126-0130)?
Weekly Report · 6d ago
Arcturus’ ARCT-2304 Flu Vaccine Trial Reaches Phase 1 Finish Line: What Investors Should Watch Next
TipRanks · 01/30 16:32
Weekly Report: what happened at ARCT last week (0119-0123)?
Weekly Report · 01/26 10:23
Analysts Are Bullish on These Healthcare Stocks: Arcturus Therapeutics (ARCT), Cerus (CERS)
TipRanks · 01/23 16:51
Analysts Conflicted on These Healthcare Names: Arcturus Therapeutics (ARCT), Newron Pharmaceuticals SpA (OtherNWPHF) and Aldeyra Therapeutics (ALDX)
TipRanks · 01/21 15:20
Weekly Report: what happened at ARCT last week (0112-0116)?
Weekly Report · 01/19 10:30
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Arcturus Therapeutics (ARCT) and Penumbra (PEN)
TipRanks · 01/16 14:10
Weekly Report: what happened at ARCT last week (0105-0109)?
Weekly Report · 01/12 10:29
More
About ARCT
Arcturus Therapeutics Holdings Inc. is a commercial mRNA medicines and vaccines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. The Company with enabling technologies, including LUNAR lipid-mediated delivery, STARR mRNA technology (sa-mRNA) and mRNA drug substances along with drug product manufacturing. It has developed KOSTAIVE, a self-amplifying messenger RNA (sa-mRNA) COVID vaccine. The Company’s pipeline includes RNA therapeutic candidates to potentially treat ornithine transcarbamylase (OTC) deficiency and cystic fibrosis (CF), along with its partnered mRNA vaccine programs for SARS-CoV-2 (COVID-19) and influenza. The Company's versatile RNA therapeutics platforms can be applied to multiple types of nucleic acid medicines, including messenger RNA, small interfering RNA, circular RNA, antisense RNA, self-amplifying RNA, DNA, and gene editing therapeutics.

Webull offers Arcturus Therapeutics Holdings Inc stock information, including NASDAQ: ARCT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ARCT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ARCT stock methods without spending real money on the virtual paper trading platform.